Earl leads the Strategy and Portfolio Management group for Medtronic Neurovascular, a developer, manufacturer and commercial organization focused on endovascular treatments for hemorrhagic and ischemic stroke, and is responsible for external technology and company acquisition and licensing. Earl joined Micro Therapeutics Inc. (MTI) in 1998 as Vice President, R&D. In 2006, MTI became a fully owned subsidiary of ev3, which was later acquired by Covidien in 2010, and then by Medtronic in 2015. From 1995 until 1998, Earl was Vice President of R&D with Aequitron Medical, Inc., a manufacturer of portable respiratory care devices. From 1992 until 1995, he was Director of Engineering with Instromedix, a manufacturer of portable EKG monitors. From 1983 to 1992, Earl held various engineering and management positions with Pfizer, Welch Allyn and Hughes Aircraft Co. Earl has over 20 issued U.S. Patents. Earl holds a bachelor’s degree in Physics with a minor in Mechanical Engineering from the University of California, San Diego. He also holds an MBA from the Tuck School of Business, Dartmouth College and an MSEE from San Diego State University.